. The distribution of the angle values between the planes of hydantoin and aromatic rings in crystal structures containing a 5-benzylidenehydantoin (hyd), 5-benzylidene-2-thiohydantoin (S-hyd) or 5-benzylidene-2-selenohydantoin (Se-hyd) fragment retrieved from the CSD. Figure S2 . The overlap of hydantoin rings of 3b (carbon atoms in grey) and 4g (carbon atoms in green). The disordered fragment of 3b is depicted only for major occupancy (A).
. The distribution of the angle values between the planes of hydantoin and aromatic rings in crystal structures containing a 5-benzylidenehydantoin (hyd), 5-benzylidene-2-thiohydantoin (S-hyd) or 5-benzylidene-2-selenohydantoin (Se-hyd) fragment retrieved from the CSD. Figure S2 . The overlap of hydantoin rings of 3b (carbon atoms in grey) and 4g (carbon atoms in green). The disordered fragment of 3b is depicted only for major occupancy (A). Figure S3 . UV-absorption spectra of tested compounds and reference UV filters obtained in methanolic solutions (for 2a-2e, 3a-3e, octocrylene and EHMC at 50 µM, for 4f-4h and avobenzone at 25 µM). Figure S4 . UV absorption spectra of tested compounds and EHMC obtained pre-irradiation and 1 hour after irradiation with solar light simulator conducted at 500 W/m 2 in 25 µM (4g) or 50 µM (2d, 3b, EHMC) methanol solutions. Figure S5 . The chromatograms and mass spectra of methanol solutions of compounds 3b and 4g preirradiation (A) and 1 hour after irradiation (B) with solar light simulator conducted at 500 W/m 2 . Table S3 . Mutagenic activity of compounds 4g and 3b tested with the Ames assay. 4.0 *FIB-fold induction over baseline (baseline = mean zero-dose control + 1 SD); SD-standard deviation **Positive controls: 2-Nitrofluorene (2-NF) at 2 µg/mL (TA98, -S9); 4-Nitroquinoline-N-oxide (4-NQO) at 0.1 µg/mL (TA100, -S9); N4-Aminocytidine (N4-ACT) at 100 µg/mL (TA1535, -S9); 9-Aminoacridine (9-AAc) at 15 µg/mL (TA1537, -S9); 4-NQO at 2 µg/mL (E.coli uvrA[pKM101], -S9); 2-Aminoanthracene (2-AA) at 0.5 µg/mL (TA98, +S9); 2-AA at 1.25 µg/mL (TA100, +S9); 9-AA at 2.5 µg/mL (TA1535 and TA1537, +S9); 2-Aminofluorene (2-AF) at 400 µg/mL (E.coli uvrA[pKM101], +S9).
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